NY Times
SEPTEMBER 13, 2020
Researchers say drug companies need to be more open about how vaccine trials are run to reassure Americans who are skittish about getting a coronavirus vaccine.
pharmaphorum
SEPTEMBER 17, 2020
Eli Lilly has followed up supportive data from its Olumiant in COVID-19 with results of a study showing its antibody treatment could help prevent hospitalisation from the disease. An interim analysis of the BLAZE-1 clinical trial showed a reduced rate of hospitalisation in patients treated with Lilly’s LY-CoV555, an antibody that neutralises the SARS-CoV-2 coronavirus, in a phase 2 trial.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
SEPTEMBER 16, 2020
The deadline for entering the 2020 PharmaTimes Communications Awards, Sales Awards and Marketer of the Year competitions has been extended to Friday October 2 after a last-minute spike in enquiries
Pharma Marketing Network
SEPTEMBER 14, 2020
Fast-tracking digital communication is now the new normal across many industries. The healthcare industry is no exception, and for pharma sales reps engaging with healthcare professionals, human connection is key. But today, communication between your reps and HCPs may be limited, or even embargoed altogether. Yet there are still a number of opportunities for engagement, and using video is one that offers various ways to maintain these connections.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Patent Watch
SEPTEMBER 18, 2020
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…. The post New patent for Boehringer Ingelheim drug OFEV appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
SEPTEMBER 18, 2020
AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company’s story, from its creation as a merger of two equals, to its recent major restructuring and its drives in cutting-edge oncology and COVID-19. In 1998, Europe’s corporate landscape was riding a “merger wave” – intensive competitive pressure meant that opportunities arose for companies to merge with their competitors in order to rationalise both businesses.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Times
SEPTEMBER 18, 2020
The drug is the first and only therapy for the ultra rare condition Familial Chylomicronaemia Syndrome (FCS)
Outsourcing Pharma
SEPTEMBER 16, 2020
CPhIâs Annual Report 2020 predicts impending cell and gene capacity shortages for the US market, and possible mAb production growth in China.
pharmaphorum
SEPTEMBER 16, 2020
It took more than a year for Don Legere to receive a diagnosis of scleroderma, a rare disease that causes the skin and connective tissues to thicken and harden, robbing people of their jobs and passions. It means that in his role as president of the New England chapter of the Scleroderma Foundation, he is determined to make sure others do not suffer the same fate.
NY Times
SEPTEMBER 16, 2020
A so-called monoclonal antibody lowered blood levels of the coronavirus and prevented hospitalizations. The research has not yet been vetted by independent experts.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
SEPTEMBER 18, 2020
The drug has been approved for routine NHS commissioning for squamous or non-squamous NSCLC
Pharma Marketing Network
SEPTEMBER 14, 2020
Fast-tracking digital communication is now the new normal across many industries. The healthcare industry is no exception, and for pharma sales reps engaging with healthcare professionals, human connection is key. But today, communication between your reps and HCPs may be limited, or even embargoed altogether. Yet there are still a number of opportunities for engagement, and using video is one that offers various ways to maintain these connections.
pharmaphorum
SEPTEMBER 16, 2020
Adding Eli Lilly’s rheumatoid arthritis drug Olumiant (baricitinib) and Gilead Sciences’ remdesivir reduces recovery time in COVID-19 patients compared to remdesivir alone, says a new trial. The ACTT-2 trial, funded by the US government and run by the National Institute for Allergy and Infectious Diseases (NIAID), involved COVID-19 patients who had been hospitalised because of severe symptoms.
Outsourcing Pharma
SEPTEMBER 16, 2020
A leader from Iqvia will present an overview of artificial intelligence, machine learning and other technology during this yearâs CPhI Festival of Pharma.
Pharma Times
SEPTEMBER 18, 2020
Concerns over NHS Test and Trace system exacerbated by continuing rise in cases
NY Times
SEPTEMBER 17, 2020
He was known for taking on difficult cases, many involving children. An anti-rejection drug he developed led to a scandal, but he was vindicated.
pharmaphorum
SEPTEMBER 15, 2020
As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. Companies like prescription glasses firm Warby Parker, shoe brand Rothy’s and tele-dentistry’s SmileDirectClub have grown up in today’s digitally native environment and can offer some key pointers for pharma.
Outsourcing Pharma
SEPTEMBER 16, 2020
In the face of the COVID-19 pandemic, CPhI Festival of Pharma organizers have shifted the event online but kept the industry content.
Pharma Times
SEPTEMBER 14, 2020
The move adds Trodelvy, a first-in-class antibody-drug conjugate approved to treat triple-negative breast cancer, to the drugmaker's portfolio
Drug Patent Watch
SEPTEMBER 15, 2020
Using data from DrugPatentWatch Fred Ledley and his research group at the Center for Integration of Science and Industry at Bentley University published a paper investigating the involvement of government…. The post Government as the First Investor in Biopharmaceutical Innovation appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
SEPTEMBER 17, 2020
US medical experts are reportedly concerned that a neurological side effect picked up in AstraZeneca’s closely-watched COVID-19 vaccine trial could compromise the whole project, as the FDA weighs whether to give the go ahead for US studies to resume. While tests of the vaccine co-developed with Oxford University have resumed in the UK, experts from the US National Institutes of Health have launched an investigation into the incident, which is still being kept under wraps by the UK pharma for pat
Outsourcing Pharma
SEPTEMBER 16, 2020
A session at the upcoming CPhI Festival of Pharma will examine supply chain, clinical trials, digitalization, and other factors impacting the field.
Pharma Times
SEPTEMBER 16, 2020
World Evidence-based Healthcare Day takes place on 20 October
Drug Patent Watch
SEPTEMBER 18, 2020
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are eighteen patents protecting…. The post New patent expiration for Acorda drug INBRIJA appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
SEPTEMBER 16, 2020
Head of “Living With”, Mariel Metcalfe, discusses the nature of severe asthma and severe eosinophilic asthma, and presents some key findings from recent patient research conducted in Europe, USA and Japan. The science behind the condition. Most people know that asthma is a chronic long-term respiratory condition in which the lung’s airways become inflamed and narrowed, making it difficult to breathe.
Outsourcing Pharma
SEPTEMBER 16, 2020
A cofounder of the Irish pharmaceutical firm will join others in sharing her perspective as a female pharmaceutical leader at this yearâs CPhI event.
Pharma Times
SEPTEMBER 17, 2020
AZ will take the programme forward into clinical development
Drug Patent Watch
SEPTEMBER 18, 2020
Annual Drug Patent Expirations for VITRAKVI Vitrakvi is a drug marketed by Bayer Hlthcare and Bayer Healthcare and is included in two NDAs. It is available from one supplier. There…. The post New patent for Bayer Healthcare drug VITRAKVI appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
SEPTEMBER 18, 2020
The pharmaceutical industry is at an inflection point, where ground-breaking innovation must be translated into transformational value for patients, healthcare professionals and society. Transformational value exists at the nexus of scientific innovation, patient-centricity, regulatory and reimbursement reform, digital technology and affordability, and refers, in part, to the extraordinary advances in science seen in recent years.
Outsourcing Pharma
SEPTEMBER 14, 2020
Merck and Seattle Genetics have announced two strategic oncology collaborations: one to develop Seattle Geneticsâ antibody-drug conjugate ladiratuzumab vedotin worldwide; and another to accelerate the global reach of Tukysa (tucatinib).
Pharma Times
SEPTEMBER 14, 2020
Under the deal the UK and Japan will incorporate functions of the existing EU/Japan Mutual Recognition Agreement for medicines
Pharma Mirror
SEPTEMBER 18, 2020
The Hague – “A common concern among pharmacy associations worldwide is the long-term financial viability of professional services delivered by pharmacists. These concerns are first and foremost triggered by the impacts of continued price and margin cuts in dispensing of medicines and the non-allocation of funding in many settings for extended professional services and social.
pharmaphorum
SEPTEMBER 18, 2020
The Patients’ Digital Health Awards (PDHA) has begun welcoming entries for its 2020 contest, which places patients at the forefront of innovation. As part of a common effort to make healthcare be about patients, not technologies or companies, the Awards’ organisers – the Digital Health Academy and MSD Foundation – have made sure patients have an active role in the initiative.
Outsourcing Pharma
SEPTEMBER 17, 2020
The US agency continues to issue advice for life-sciences professionals engaged in work related to the virus, and keep an eye out for fraudulent products.
Pharma Times
SEPTEMBER 17, 2020
Over half of patients treated with combination therapy were alive and relapse-free after five years
Expert insights. Personalized for you.
140 
Let's personalize your content